PMA device
Propel
Intersect Ent. · Drug-Eluting Sinus Stent (OWO, Class III) · First FDA decision Aug 11, 2011, newest Feb 28, 2020Chronic sinusitis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
43
Naming "Propel"
MAUDE reports
36
Brand "Propel", since 2015
PubMed studies
3,971
Mentioning "Propel"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Propel
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- PropelPMA supplement
P100044-S043 · Decided Feb 28, 2020 · 178 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
- PROPELPMA supplement
P100044-S020 · Decided Aug 24, 2016 · 152 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
- PROPEL SINUS IMPLANT, PROPEL MINI SINUS IMPLANTPMA supplement
P100044-S017 · Decided May 7, 2015 · 35 days after receipt · Normal 180 Day Track No User Fee
Device type: Drug-eluting sinus stent (OWO) · Otolaryngology (ENT)
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Propel", any status and sponsor, newest update first.
- A Study of Different Skin Care Approaches to Prevent Skin Reactions in People With Breast Cancer Receiving Radiation Therapy After MastectomyPivotal-lookingRecruiting
Memorial Sloan Kettering Cancer CenterAcademic, hospital or other
NCT07918989 · 138 participants (planned) · Start Oct 30, 2026 · Primary completion Oct 30, 2028
Device: Mepitel Film · For: Breast Cancer; Breast Cancer Female
Sites: Basking Ridge, New Jersey; Middletown, New Jersey; Montvale, New Jersey · 7 sites in all
OssDsignNot on our public-company list
NCT05329129 · 450 participants (planned) · Start Mar 23, 2022 · Primary completion Mar 23, 2030
Device: OssDsign® Catalyst · For: Degenerative Disc Disease; Spinal Stenosis
Sites: Fresno, California; Long Beach, California; San Diego, California · 16 sites in all
Polyganics BVNot on our public-company list
NCT06642116 · 10 participants · Start Feb 10, 2025 · Primary completion Jun 17, 2025
Device: OCEAN · For: Rhinosinusitis Chronic; Wound Healing; Sinus Surgery and 1 more
Sites: Baltimore, Maryland; Detroit, Michigan; Ogden, Utah
40 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Propel", and for the whole product code for context.
This brand
36 reports: 9 malfunction, 27 injury, 0 death
Whole product code OWO
36 reports: 7 malfunction, 29 injury, 0 death
Newest reports for this brand
3008301917-2026-00001 · Received Sep 30, 2026 · Event dated Aug 27, 2026
Device type: Drug-Eluting Sinus Stent (OWO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bacterial Infection; Nasal Obstruction; Sinusitis
- PROPELMalfunction
23004762 · Received Sep 9, 2025 · Event dated Jul 17, 2025
Device type: Drug-Eluting Sinus Stent (OWO)
Device problem as coded: Activation Failure
Patient problem as coded: Insufficient Information
3008301917-2024-00002 · Received Aug 30, 2024 · Event dated Mar 10, 2024
Device type: Drug-Eluting Sinus Stent (OWO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Chemosis; Headache; Unspecified Infection; Impaired Healing; Sinusitis
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Propel"[tiab]. The summary above synthesizes these.
- Supercoiled filaments propel them all.
Popp PF, Erhardt M · Cell · 2022Research Support, Non-U.S. Gov't, Comment
- What Is Addiction? History, Terminology, and Core Concepts.
Olsen Y · Med Clin North Am · 2022Historical Article, Review
- Vibrio Flagellar Synthesis.
Echazarreta MA, Klose KE · Front Cell Infect Microbiol · 2019Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- 3D Spheroids Propel Tumor Characterization.
Li S, Zhang Z, Han L · Trends Cancer · 2020Research Support, Non-U.S. Gov't
- Finding and Conjuring.
Pinto S · Med Anthropol · 2018
- Marine migrations.
Putman N · Curr Biol · 2018
- Neural Signaling in Cancer.
Keough MB, Monje M · Annu Rev Neurosci · 2022Review, Research Support, N.I.H., Extramural
- Lymphatic Clearance and Pump Function.
Breslin JW · Cold Spring Harb Perspect Med · 2023Review, Research Support, N.I.H., Extramural
- Water-Compatible Staudinger-Diels-Alder Ligation.
Tanioka M, Kanayama S, Kitamura F, et al. · J Org Chem · 2025
- Development of a multiciliated cell.
Mahjoub MR, Nanjundappa R, Harvey MN · Curr Opin Cell Biol · 2022Review, Research Support, N.I.H., Extramural
- Illuminating RNA biology through imaging.
Le P, Ahmed N, Yeo GW · Nat Cell Biol · 2022Review, Research Support, Non-U.S. Gov't
- Artificial Intelligence to Propel Evidence Generation.
Dhruva SS, Curtis LH, Califf RM · J Am Coll Cardiol · 2026Editorial
Other devices of this type
Also filed under product code OWO.
- Propel Mini Sinus ImplantIntersect Ent. · PMA 2016
- Propel Contour Sinus ImplantIntersect Ent. · PMA 2017
- Intersect Ent Propel Mini Sinus ImplantIntersect Ent. · PMA 2014
- Intersectent Propel Mini Sinus ImplantIntersect Ent. · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.